The addition of trastuzumab and pertuzumab to chemotherapy was associated with increased toxicity in patients with ...
Objective To determine whether new users of proton pump inhibitors (PPIs) are at an increased risk of gastric cancer compared with new users of histamine-2 receptor antagonists (H2RAs). Design Using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback